|CUV -- Germany Stock|| |
EUR 0.49 0.011 2.29%
Dr. Dennis J. Wright, BPharm, MSc, Ph.D., is Acting Chief Scientific Officer of Clinuvel Pharmaceuticals Ltd since September 2012. He was previously Vice President Scientific Affairs of the Company. Dr. Wright has a range of experience in the pharmaceutical industry spanning 25 years. He spent more than 17 years at CSL working predominantly in regulatory affairs with nearly a decade as Regulatory Affairs Manager. Most recently he was Global Pharmacovigilance Manager and Regulatory Affairs Manager for the Australian and New Zealand operations of Mayne Pharma, a company recently acquired by Halcygen . He has a Pharmacy degree and postgraduate qualifications from University of Sydney and Health Economics qualifications from Monash University, Melbourne
Executive Since 2012
Wright is responsible for the clinical and regulatory development team and progressing afamelanotide through to regulatory approval in global markets.